SXTP
Price
$1.56
Change
-$0.14 (-8.24%)
Updated
Mar 4, 11:22 AM (EDT)
Capitalization
2.67M
71 days until earnings call
VIGL
Price
$2.17
Change
-$0.02 (-0.91%)
Updated
Mar 4, 11:37 AM (EDT)
Capitalization
98.93M
16 days until earnings call
Ad is loading...

SXTP vs VIGL

Header iconSXTP vs VIGL Comparison
Open Charts SXTP vs VIGLBanner chart's image
60 Degrees Pharmaceuticals
Price$1.56
Change-$0.14 (-8.24%)
Volume$100
Capitalization2.67M
Vigil Neuroscience
Price$2.17
Change-$0.02 (-0.91%)
Volume$100
Capitalization98.93M
SXTP vs VIGL Comparison Chart
Loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SXTP vs. VIGL commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXTP is a Hold and VIGL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (SXTP: $1.73 vs. VIGL: $2.19)
Brand notoriety: SXTP and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SXTP: 12% vs. VIGL: 16%
Market capitalization -- SXTP: $2.67M vs. VIGL: $98.93M
SXTP [@Biotechnology] is valued at $2.67M. VIGL’s [@Biotechnology] market capitalization is $98.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SXTP’s FA Score shows that 1 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • SXTP’s FA Score: 1 green, 4 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, VIGL is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SXTP’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 5 bullish TA indicator(s).

  • SXTP’s TA Score: 4 bullish, 4 bearish.
  • VIGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both SXTP and VIGL are a good buy in the short-term.

Price Growth

SXTP (@Biotechnology) experienced а -18.50% price change this week, while VIGL (@Biotechnology) price change was -17.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -11.04%, and the average quarterly price growth was -7.19%.

Reported Earning Dates

SXTP is expected to report earnings on May 14, 2025.

VIGL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($98.9M) has a higher market cap than SXTP($2.67M). VIGL YTD gains are higher at: 28.824 vs. SXTP (-73.212). SXTP has higher annual earnings (EBITDA): -7.87M vs. VIGL (-87.97M). VIGL has more cash in the bank: 111M vs. SXTP (1.58M). SXTP has less debt than VIGL: SXTP (157K) vs VIGL (13.2M). SXTP has higher revenues than VIGL: SXTP (502K) vs VIGL (0).
SXTPVIGLSXTP / VIGL
Capitalization2.67M98.9M3%
EBITDA-7.87M-87.97M9%
Gain YTD-73.21228.824-254%
P/E RatioN/AN/A-
Revenue502K0-
Total Cash1.58M111M1%
Total Debt157K13.2M1%
TECHNICAL ANALYSIS
Technical Analysis
SXTPVIGL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PALI0.81-0.02
-1.91%
Palisade Bio
PIII0.18N/A
-2.38%
P3 Health Partners
MIRM46.03-1.54
-3.24%
Mirum Pharmaceuticals
CDNA21.14-1.01
-4.56%
CareDx
SRPT101.24-5.51
-5.16%
Sarepta Therapeutics

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and CLDX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and CLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-4.54%
CLDX - SXTP
24%
Poorly correlated
-5.93%
XFOR - SXTP
24%
Poorly correlated
-8.58%
CMRX - SXTP
23%
Poorly correlated
-4.00%
CDIO - SXTP
23%
Poorly correlated
-5.83%
ABSI - SXTP
22%
Poorly correlated
-11.30%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with ALEC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
-9.50%
ALEC - VIGL
35%
Loosely correlated
-13.41%
FHTX - VIGL
33%
Poorly correlated
-10.52%
PTGX - VIGL
32%
Poorly correlated
+2.42%
OABI - VIGL
32%
Poorly correlated
-1.58%
CLDX - VIGL
32%
Poorly correlated
-5.93%
More